Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV protease inhibitors, the lipodystrophy syndrome and polycystic ovary syndrome--is there a link?

Sexually transmitted infections - 1 Aug 1999

Wilson J D, Dunham R J, Balen A H

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Predisposition to Disease
Share to HIV Infections
Share to HIV Protease Inhibitors
Share to Insulin Resistance

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lipodystrophy

Share to Polycystic Ovary Syndrome

Source

Open in PubMed Open full text

Identifiers

PMID: 10615316
DOI: 10.1136/sti.75.4.268
PMCID: PMC1758228

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV protease inhibitors, the lipodystrophy syndrome and polycystic ovary syndrome--is there a link?PMID 10615316Read ↗

Pharmacogenetics of the lipodystrophy syndrome associated with HIV infection and combination antiretroviral therapy.Semantic proximity Read ↗

British HIV Association guidelines for antiretroviral treatment of HIV-2-positive individuals 2010.Semantic proximity Read ↗

A Critical Review of the Biochemical Mechanisms and Epigenetic Modifications in HIV- and Antiretroviral-Induced Metabolic SyndromeSemantic proximity Read ↗

[Lipodystrophy syndrome of patients infected by HIV receiving antiretroviral treatment].Semantic proximity Read ↗

Association between the APOC3 (rs2854116), ESR2 (rs3020450), HFE (rs1799945), and MMP1 (rs1799750) gene polymorphisms and lipodystrophy in people living with HIV receiving antiretroviral therapy.Semantic proximity Read ↗

[Lipodystrophic syndromes in HIV-infected patients receiving antiretroviral treatment].Semantic proximity Read ↗

Effect of genetic variations in drug transporters, metabolizing enzyme and regulatory genes on the development of HIV-associated lipodystrophy.Semantic proximity Read ↗

HIV associated lipodystrophy : study of molecular mechanisms and genetic susceptibilitySemantic proximity Read ↗

Anti-HIV agents. Monotherapy studies--points to consider.Semantic proximity Read ↗

Interventions for body habitus changes associated with HIV infection and its treatment.Semantic proximity Read ↗

Clinical update: adverse effects of antiretroviral therapySemantic proximity Read ↗

Association of the polymorphisms of the genes APOC3 (rs2854116), ESR2 (rs3020450), HFE (rs1799945), MMP1 (rs1799750) and PPARG (rs1801282) with lipodystrophy in people living with HIV on antiretroviral therapy: a systematic review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.